Market Overview:
The global hemodialysis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of renal failure, rising geriatric population, and technological advancements in hemodialysis machines. Based on type, the global hemodialysis market is segmented into hemodialysis machines (HD), hemodiafiltration machines (HF), and bedside hemodiafiltration machines (bedside machines or bedside blood filtration). Hemodiafiltration machine segment is expected to grow at a higher CAGR during the forecast period as compared to other segments owing to its benefits such as high efficiency for removal of toxins from blood and extended dialyzer life. Based on application, the global hemodialysis market is segmented into acute renal failure, chronic renal failure, acute drug poisoning or poison, and other applications. Acute renal failure accounted for majority share of the global hemodialyses market in 2017 owing to high incidence rate of this condition across globe.
Product Definition:
Hemodialysis is a medical procedure that uses a dialysis machine to remove waste and excess fluid from the blood. It is used to treat people with kidney failure.
Hemodialysis Machine (HD):
Hemodialysis machine (HD) is used to cleanse and separate blood in the kidney. It is an artificial device that cleanses the blood of toxins, extra fluids, and other materials that are found in it. The machine also helps remove around 90% of the waste products from the blood.
Hemodiafiltration machine (HF):
Hemodiafiltration machine (HF) is used in hemodialysis process. It removes blood clots from blood vessels and helps in increasing the blood flow rate to maintain the strength of kidney function.
Application Insights:
Based on the application, the global hemodialysis market is segmented into acute renal failure, chronic renal failure, other diseases and others. Acute renal failure held the largest share in 2017 owing to an increase in cases of kidney failures and a growing number of dialysis centers. According to data published by U.S Renal Data Foundation in 2018, over 585 thousand people suffer from acute kidney failures across America which requires regular dialysis or a transplantation procedure. The same year saw more than 37 thousand patients undergo ESRD treatment while around 24 thousand people were diagnosed with CKD during that same year alone according to estimates published by CDC (U.S).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from kidney diseases, increasing healthcare expenditure, and rising awareness about blood donation. In addition, growing preference for home health care services is expected to drive regional growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to an increase in healthcare expenditure by governments and private sectors along with improving infrastructure facilities for treating kidney diseases. Moreover, rise in diabetes-related disorders that result into chronic renal failure cases are also driving regional demand. Increasing incidence of acute renal failure cases due to cardiac arrest or trauma also drives this market demand during emergency situations such as war or natural disasters when there is a need for immediate dialysis procedures instead of waiting list basis at hospitals across developing countries such as India & China & Bangladesh etc.
Growth Factors:
- Increasing incidence of renal diseases: The global prevalence of chronic kidney disease is expected to increase from 9% in 2010 to 14% by 2025. This will create a large pool of patients who will require hemodialysis treatment.
- Technological advancements: Hemodialysis equipment and technologies are constantly evolving, with new products and devices being launched regularly. This is helping to improve the quality and efficiency of hemodialysis treatments, making them more accessible to patients worldwide.
- Growing awareness about dialysis treatments: There is growing awareness among both patients and healthcare professionals about the benefits of hemodialysis over other renal replacement therapies such as peritoneal dialysis or transplantation. This is helping to drive demand for hemodialysis services globally.
- creating a large pool of elderly patients who are at high risk for developing chronic kidney disease
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemodialysis Market Research Report
By Type
Hemodialysis Machine (HD), Hemodiafiltration machine (HF), Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
By Application
Acute renal failure, Chronic renal failure, Acute drug poisoning or poison, Other
By Companies
Fresenius, Baxter & Gambro, B.Braum, Nikkiso, Toray, Nipro, Bellco, Asahi Kasei, WEGO, Shanwaishan, Jihua
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Hemodialysis Market Report Segments:
The global Hemodialysis market is segmented on the basis of:
Types
Hemodialysis Machine (HD), Hemodiafiltration machine (HF), Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acute renal failure, Chronic renal failure, Acute drug poisoning or poison, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius
- Baxter & Gambro
- B.Braum
- Nikkiso
- Toray
- Nipro
- Bellco
- Asahi Kasei
- WEGO
- Shanwaishan
- Jihua
Highlights of The Hemodialysis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemodialysis Machine (HD)
- Hemodiafiltration machine (HF)
- Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
- By Application:
- Acute renal failure
- Chronic renal failure
- Acute drug poisoning or poison
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemodialysis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemodialysis is a process that removes waste and toxins from the blood. It is used to treat people with kidney failure.
Some of the major players in the hemodialysis market are Fresenius, Baxter & Gambro, B.Braum, Nikkiso, Toray, Nipro, Bellco, Asahi Kasei, WEGO, Shanwaishan, Jihua.
The hemodialysis market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemodialysis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemodialysis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemodialysis Market - Supply Chain
4.5. Global Hemodialysis Market Forecast
4.5.1. Hemodialysis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemodialysis Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemodialysis Market Absolute $ Opportunity
5. Global Hemodialysis Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemodialysis Market Size and Volume Forecast by Type
5.3.1. Hemodialysis Machine (HD)
5.3.2. Hemodiafiltration machine (HF)
5.3.3. Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemodialysis Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemodialysis Market Size and Volume Forecast by Application
6.3.1. Acute renal failure
6.3.2. Chronic renal failure
6.3.3. Acute drug poisoning or poison
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemodialysis Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemodialysis Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemodialysis Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemodialysis Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemodialysis Demand Share Forecast, 2019-2026
9. North America Hemodialysis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemodialysis Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemodialysis Market Size and Volume Forecast by Application
9.4.1. Acute renal failure
9.4.2. Chronic renal failure
9.4.3. Acute drug poisoning or poison
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemodialysis Market Size and Volume Forecast by Type
9.7.1. Hemodialysis Machine (HD)
9.7.2. Hemodiafiltration machine (HF)
9.7.3. Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemodialysis Demand Share Forecast, 2019-2026
10. Latin America Hemodialysis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemodialysis Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemodialysis Market Size and Volume Forecast by Application
10.4.1. Acute renal failure
10.4.2. Chronic renal failure
10.4.3. Acute drug poisoning or poison
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemodialysis Market Size and Volume Forecast by Type
10.7.1. Hemodialysis Machine (HD)
10.7.2. Hemodiafiltration machine (HF)
10.7.3. Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemodialysis Demand Share Forecast, 2019-2026
11. Europe Hemodialysis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemodialysis Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemodialysis Market Size and Volume Forecast by Application
11.4.1. Acute renal failure
11.4.2. Chronic renal failure
11.4.3. Acute drug poisoning or poison
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemodialysis Market Size and Volume Forecast by Type
11.7.1. Hemodialysis Machine (HD)
11.7.2. Hemodiafiltration machine (HF)
11.7.3. Bedside hemodiafiltration machines (bedside machins or bedside blood filtration)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemodialysis Demand Share, 2019-2026
12. Asia Pacific Hemodialysis Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemodialysis Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemodialysis Market Size and Volume Forecast by Application
12.4.1. Acute renal failure
12.4.2. Chronic renal failure
12.4.3. Acute drug poisoning or poison
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemodialysis Market Size and Volume Forecast by Type
12.7.1. Hemodialysis Machine (HD)
12.7.2. Hemodiafiltration machine (HF)
12.7.3. Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemodialysis Demand Share, 2019-2026
13. Middle East & Africa Hemodialysis Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemodialysis Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemodialysis Market Size and Volume Forecast by Application
13.4.1. Acute renal failure
13.4.2. Chronic renal failure
13.4.3. Acute drug poisoning or poison
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemodialysis Market Size and Volume Forecast by Type
13.7.1. Hemodialysis Machine (HD)
13.7.2. Hemodiafiltration machine (HF)
13.7.3. Bedside hemodiafiltration machines (bedside machines or bedside blood filtration)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemodialysis Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemodialysis Market: Market Share Analysis
14.2. Hemodialysis Distributors and Customers
14.3. Hemodialysis Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fresenius
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter & Gambro
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B.Braum
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Nikkiso
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Toray
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nipro
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bellco
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Asahi Kasei
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. WEGO
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Shanwaishan
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Jihua
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
